Archives: Speakers

20y+ experience within pharmaceutical industry and specially within clinical supply chain, Digital development, and innovation.

Career started as a biochemist engineer, Landry has moved progressively to drug manufacturing process development, GMP production, comparator supply & material flow management and then innovation and technology for clinical supplies.

Key drivers of his career are continuous improvement, factual based decision and valuable innovation implementation.

Dr Katriona Brooksbank holds a BSc (Hons) in Genetics (Immunology) and a PhD in Medicine and Therapeutics from the University of Aberdeen.

With experience spanning academia, industry, and the health service both in the UK and internationally, Katriona has specialised in the ethical design and delivery of observational health research and clinical trials, as well as innovation and technology evidence generation in healthcare. To complement her postdoctoral work in novel therapeutics—including digital solutions and AI as a medical device—she completed a Master of Laws in Medical Law and Ethics.

Currently, Katriona is the R&I Innovation Lead for WosIH (core CSO funded), supporting innovation across Health Boards in the West of Scotland and collaborating closely with colleagues in the North and East of Scotland. She is Co-Chair of the AI Governance Group, a member of the National Steering Committee for AI deployment, and Chair of the Health Research Authority Research Ethics Committee (WoSREC1).

As Intellectual Property Officer at NHSGGC, she supports benefit sharing with partners. Katriona is also an Honorary Associate Professor at the University of Glasgow, teaching and directing the MSc in MedTech Innovation and leading courses on ethics, regulation, and governance.

Ana-Zeralda Canals Hamann is an Associate Director in Clinical Trial Supplies & CMC Project Leader at Debiopharm International SA based in Lausanne, Switzerland. A clinical supply chain leader with over 15 years of experience, she specializes in CMC, logistics, and operations within complex, international biopharmaceutical environments.

She has a proven record of building global clinical supply strategies across multiple therapeutic areas, including oncology and rare diseases. Her operational expertise spans GxP/GMP/GDP compliance, digitalization, sustainability, and Lean transformation. She is actively involved in the industry as a Committee Member and former Chair of the European Global Clinical Supplies Group (GCSG) and serves on the Research Ethics Committee at Queen Mary University of London.